74 studies found for:    MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1
Show Display Options
Rank Status Study
21 Recruiting Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department
Conditions: Probable Migraine;   Migraine With Aura;   Migraine Without Aura
Interventions: Drug: Ketorolac Tromethamine;   Drug: Metoclopramide
22 Recruiting Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine
Conditions: Migraine With Aura;   Migraine Without Aura
Interventions: Other: Sham chiropractic manipulative therapy;   Other: Chiropractic spinal manipulative therapy
23 Completed Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study
Conditions: Migraine Without Aura;   Migraine With Aura
Interventions: Drug: Placebo;   Drug: Eletriptan HBr 40 mg;   Drug: Eletriptan HBr 80 mg
24 Unknown  Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura
Condition: Migraine With Aura
Interventions: Drug: NXN-188;   Drug: Placebo
25 Completed Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
Conditions: Migraine Without Aura;   Migraine With Aura
Interventions: Drug: Tonabersat;   Drug: Placebo
26 Completed Impact of tDCS on Cerebral Autoregulation
Conditions: Cerebral Microangiopathy;   CADASIL;   Migraine With Aura;   ICA Stenosis
Interventions: Device: Anodal tDCS;   Device: Cathodal tDCS;   Device: sham tDCS
27 Recruiting The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine
Conditions: Migraine Disorders;   Headache, Migraine;   Migraine;   Migraine Headache;   Migraine With Aura;   Migraine Without Aura;   Headache Disorders, Primary
Interventions: Drug: Triptan;   Drug: Doxycycline
28 Completed Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine
Conditions: Migraine With Aura;   Migraine Without Aura
Intervention: Drug: Laxymig ER (drug)
29 Completed Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment
Conditions: Migraine With Aura;   Migraine Without Aura
Intervention: Drug: Sumatriptan+Promethazine (SPr)
30 Terminated
Has Results
A Study of a Melatonin Receptor Agonist to Prevent Migraine
Conditions: Migraine;   Migraine With Aura;   Migraine Without Aura
Interventions: Drug: Ramelteon;   Drug: Placebo
31 Unknown  Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine
Conditions: Migraine;   Migraine Headache;   Migraine Disorders;   Migraine With Aura;   Migraine Without Aura
Interventions: Drug: AST-726 Low dose;   Drug: AST-726 High dose;   Drug: AST-726 Placebo
32 Completed Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
Conditions: Migraine Without Aura;   Migraine With Aura
Interventions: Drug: Tonabersat;   Drug: Placebo
33 Recruiting Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow by Hypoxia
Conditions: Headache;   Migraine;   Aura
Interventions: Other: Hypoxia;   Other: Placebo
34 Completed
Has Results
A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period
Conditions: Migraine With or Without Aura;   Migraine Disorders;   Migraine, Acute;   Migraine Headaches
Interventions: Drug: sumatriptan and naproxen sodium combination tablet;   Drug: sumatriptan tablet;   Drug: naproxen sodium tablet
35 Completed
Has Results
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)
Conditions: Migraine With or Without Aura;   Migraine Disorders;   Migraine
Interventions: Drug: Placebo;   Drug: Combination Product (sumatriptan succinate/naproxen sodium)
36 Completed An Open-labeled Trial of Ramipril in Patients With Migraine
Condition: Migraine With Hypertension
Intervention: Drug: Ramipril
37 Completed An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate)
Conditions: Migraine With or Without Aura;   Migraine Disorders;   Cluster Headache;   Migraine
Interventions: Drug: TREXIMA™;   Drug: IMITREX®  (4mg);   Drug: IMITREX® (6mg);   Drug: IMITREX Tablet 100mg
38 Completed TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine
Conditions: Migraine With or Without Aura;   Migraine Disorders
Interventions: Drug: Combination Product (sumatriptan succinate / naproxen sodium);   Drug: RELPAX(eletriptan) 40mg Tablet
39 Completed Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan
Condition: Migraine With or Without Aura
Interventions: Drug: Placebo;   Drug: Eletriptan 40 mg;   Drug: Eletriptan 80 mg
40 Completed Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo
Condition: Migraine With or Without Aura
Interventions: Drug: Placebo;   Drug: Eletriptan 40 mg;   Drug: Eletriptan 80 mg;   Drug: Sumatriptan 25 mg;   Drug: Sumatriptan 50 mg

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years